Robinhood Markets, Inc.’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$278 Buy
+24
New +$392 ﹤0.01% 947

Other funds holding MLTX

Robinhood Markets, Inc.'s MLTX Position: Q3 2026 in Review

Robinhood Markets, Inc. opened a new position in MoonLake Immunotherapeutics (MLTX) in Q3 2026: 24 shares worth $278. The stake represents ﹤0.01% of the portfolio and ranks #947 among its holdings.

169 funds tracked by Wall St. Rank hold MLTX as of Q3 2026.

  • Robinhood Markets, Inc. held 24 shares of MoonLake Immunotherapeutics worth $278 as of Q3 2026.
  • MoonLake Immunotherapeutics was a new Robinhood Markets, Inc. position in Q3 2026.
  • MoonLake Immunotherapeutics made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #947 holding.
  • 169 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q3 2026.

Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.